Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1970 1
1971 3
1972 2
1973 3
1986 1
1995 1
1999 1
2001 2
2003 1
2007 2
2008 4
2009 3
2010 2
2011 6
2012 10
2013 6
2014 9
2015 8
2016 10
2017 8
2018 8
2019 4
2020 8
2021 11
2022 5
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

102 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Page 1
Isobutylamido thiazolyl resorcinol for prevention of UVB-induced hyperpigmentation.
Vachiramon V, Kositkuljorn C, Leerunyakul K, Chanprapaph K. Vachiramon V, et al. J Cosmet Dermatol. 2021 Mar;20(3):987-992. doi: 10.1111/jocd.13615. Epub 2020 Aug 5. J Cosmet Dermatol. 2021. PMID: 32757247 Clinical Trial.
BACKGROUND: Isobutylamido thiazolyl resorcinol (ITR, Thiamidol() ) has been proposed as a potent tyrosinase inhibitor. ...
BACKGROUND: Isobutylamido thiazolyl resorcinol (ITR, Thiamidol() ) has been proposed as a potent tyrosinase inhibitor. ...
Phase 3 Trials of Tapinarof Cream for Plaque Psoriasis.
Lebwohl MG, Stein Gold L, Strober B, Papp KA, Armstrong AW, Bagel J, Kircik L, Ehst B, Hong HC, Soung J, Fromowitz J, Guenthner S, Piscitelli SC, Rubenstein DS, Brown PM, Tallman AM, Bissonnette R. Lebwohl MG, et al. N Engl J Med. 2021 Dec 9;385(24):2219-2229. doi: 10.1056/NEJMoa2103629. N Engl J Med. 2021. PMID: 34879448 Clinical Trial.
Inhibition of Human Tyrosinase Requires Molecular Motifs Distinctively Different from Mushroom Tyrosinase.
Mann T, Gerwat W, Batzer J, Eggers K, Scherner C, Wenck H, Stäb F, Hearing VJ, Röhm KH, Kolbe L. Mann T, et al. J Invest Dermatol. 2018 Jul;138(7):1601-1608. doi: 10.1016/j.jid.2018.01.019. Epub 2018 Feb 7. J Invest Dermatol. 2018. PMID: 29427586 Free article. Clinical Trial.
The most potent inhibitors of human tyrosinase identified in this screen were resorcinyl-thiazole derivatives, especially the newly identified Thiamidol (Beiersdorf AG, Hamburg, Germany) (isobutylamido thiazolyl resorcinol), which had an IC(50) of 1.1 mumol/L. In contrast, …
The most potent inhibitors of human tyrosinase identified in this screen were resorcinyl-thiazole derivatives, especially the newly identifi …
Clinical efficacy and safety of nano-microneedle-assisted phenylethyl resorcinol for the treatment of infraorbital dark circles.
Yu CQ, Xu XG, Chen HD, Li YH. Yu CQ, et al. J Cosmet Dermatol. 2021 Mar;20(3):884-889. doi: 10.1111/jocd.13641. Epub 2020 Aug 11. J Cosmet Dermatol. 2021. PMID: 32783330 Clinical Trial.
The objective of this study was to evaluate the efficacy and safety of nano-microneedle-assisted phenylethyl resorcinol (PR) for the treatment of infraorbital dark circles. METHODS: Twenty female participants were randomized to two groups. ...
The objective of this study was to evaluate the efficacy and safety of nano-microneedle-assisted phenylethyl resorcinol (PR) for the …
Efficacy of isobutylamido thiazolyl resorcinol for prevention of laser-induced post-inflammatory hyperpigmentation: A randomized, controlled trial.
Vachiramon V, Sakpuwadol N, Yongpisarn T, Anuntrangsee T, Palakornkitti P. Vachiramon V, et al. J Cosmet Dermatol. 2024 Jul;23(7):2450-2457. doi: 10.1111/jocd.16287. Epub 2024 Mar 18. J Cosmet Dermatol. 2024. PMID: 38497328 Clinical Trial.
However, the incidence of post-inflammatory hyperpigmentation (PIH) is a common complication, especially in dark-complexioned skin. Isobutylamido thiazolyl resorcinol (ITR) has been reported as a preventive modality for ultraviolet B (UVB)-induced hyperpigmentation. ...
However, the incidence of post-inflammatory hyperpigmentation (PIH) is a common complication, especially in dark-complexioned skin. Isobutyl …
Efficacy and safety of 0.15% isobutylamido thiazolyl resorcinol combined with hyaluronic acid vs 0.15% isobutylamido thiazolyl resorcinol or hyaluronic acid alone in melasma treatment: A randomized evaluator-blind trial.
Disphanurat W, Srisantithum B. Disphanurat W, et al. J Cosmet Dermatol. 2021 Nov;20(11):3563-3572. doi: 10.1111/jocd.14031. Epub 2021 Mar 10. J Cosmet Dermatol. 2021. PMID: 33638926 Clinical Trial.
BACKGROUND: Melasma has a complex pathogenesis, and various aggravating factors contribute to its recalcitrance to treatments. A combination of isobutylamido thiazolyl resorcinol (ITR) and hyaluronic acid (HA) could increase melasma treatment efficacy. ...
BACKGROUND: Melasma has a complex pathogenesis, and various aggravating factors contribute to its recalcitrance to treatments. A combination …
102 results